Literature DB >> 9835539

In vitro activities of membrane-active peptides against gram-positive and gram-negative aerobic bacteria.

A Giacometti1, O Cirioni, G Greganti, M Quarta, G Scalise.   

Abstract

Four peptides, cecropin P1, magainin II, indolicidin, and ranalexin, were evaluated against 202 clinical isolates of gram-positive and gram-negative aerobic bacteria by a microbroth dilution method. The gram-negative isolates were more susceptible to cecropin P1. Ranalexin was the most active compound against the gram-positive strains. The bactericidal activity of each peptide was equivalent to, or 1 dilution above, the MIC. In conclusion, the four peptides exhibited different in vitro activities and rapid time-dependent killing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9835539      PMCID: PMC106047     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Antibacterial peptides and the outer membranes of gram-negative bacilli.

Authors:  R E Hancock
Journal:  J Med Microbiol       Date:  1997-01       Impact factor: 2.472

2.  Fungicidal activity of cecropin A.

Authors:  A J DeLucca; J M Bland; T J Jacks; C Grimm; T E Cleveland; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

3.  Antimicrobial peptides. A family of wound healers.

Authors:  M Cannon
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

4.  N-terminal analogues of cecropin A: synthesis, antibacterial activity, and conformational properties.

Authors:  D Andreu; R B Merrifield; H Steiner; H G Boman
Journal:  Biochemistry       Date:  1985-03-26       Impact factor: 3.162

Review 5.  Cell-free immunity in insects.

Authors:  H G Boman; D Hultmark
Journal:  Annu Rev Microbiol       Date:  1987       Impact factor: 15.500

6.  All-D amino acid-containing channel-forming antibiotic peptides.

Authors:  D Wade; A Boman; B Wåhlin; C M Drain; D Andreu; H G Boman; R B Merrifield
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.

Authors:  R I Lehrer; A Barton; K A Daher; S S Harwig; T Ganz; M E Selsted
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

8.  Antibacterial peptides from pig intestine: isolation of a mammalian cecropin.

Authors:  J Y Lee; A Boman; C X Sun; M Andersson; H Jörnvall; V Mutt; H G Boman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria.

Authors:  M Vaara; M Porro
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

10.  Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa.

Authors:  J G Sawyer; N L Martin; R E Hancock
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

View more
  11 in total

1.  In vitro susceptibility tests for cationic peptides: comparison of broth microdilution methods for bacteria that grow aerobically.

Authors:  A Giacometti; O Cirioni; F Barchiesi; M S Del Prete; M Fortuna; F Caselli; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Interaction of the gelsolin-derived antibacterial PBP 10 peptide with lipid bilayers and cell membranes.

Authors:  Robert Bucki; Paul A Janmey
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 3.  Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations.

Authors:  Manuel N Melo; Rafael Ferre; Miguel A R B Castanho
Journal:  Nat Rev Microbiol       Date:  2009-03       Impact factor: 60.633

4.  Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model.

Authors:  Oscar Cirioni; Andrea Giacometti; Roberto Ghiselli; Federico Mocchegiani; Anna Fineo; Fiorenza Orlando; Maria Simona Del Prete; Marco Rocchi; Vittorio Saba; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

5.  In vitro microbicidal activities of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatis.

Authors:  L M Ballweber; J E Jaynes; W E Stamm; M F Lampe
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

6.  Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13.

Authors:  Robert Bucki; Dorota B Namiot; Zbigniew Namiot; Paul B Savage; Paul A Janmey
Journal:  J Antimicrob Chemother       Date:  2008-05-01       Impact factor: 5.790

7.  In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms.

Authors:  Emel Mataraci; Sibel Dosler
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

8.  Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus.

Authors:  Ian M Overton; Shirley Graham; Katherine A Gould; Jason Hinds; Catherine H Botting; Sally Shirran; Geoffrey J Barton; Peter J Coote
Journal:  BMC Syst Biol       Date:  2011-05-12

9.  Prediction of antibacterial activity from physicochemical properties of antimicrobial peptides.

Authors:  Manuel N Melo; Rafael Ferre; Lídia Feliu; Eduard Bardají; Marta Planas; Miguel A R B Castanho
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

10.  Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.

Authors:  Joelle Jodoin; Maxwell T Hincke
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.